Zhejiang Taimei Medical Technology Co., Ltd.
Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders; PharmaOS, a pharmaceutical digital marketing platform; and Ente… Read more
Zhejiang Taimei Medical Technology Co., Ltd. - Asset Resilience Ratio
Zhejiang Taimei Medical Technology Co., Ltd. (A2V) has an Asset Resilience Ratio of 59.01% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Zhejiang Taimei Medical Technology Co., Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Taimei Medical Technology Co., Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €896.15 Million | 59.01% |
| Total Liquid Assets | €896.15 Million | 59.01% |
Asset Resilience Insights
- Very High Liquidity: Zhejiang Taimei Medical Technology Co., Ltd. maintains exceptional liquid asset reserves at 59.01% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Taimei Medical Technology Co., Ltd. Industry Peers by Asset Resilience Ratio
Compare Zhejiang Taimei Medical Technology Co., Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
UCrest Bhd
KLSE:0005 |
Health Information Services | 24.81% |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638 |
Health Information Services | 0.49% |
|
BIT Computer Co. Ltd
KQ:032850 |
Health Information Services | 26.87% |
|
ezCaretech Co. LTD
KQ:099750 |
Health Information Services | 16.56% |
|
SyntekaBio Inc
KQ:226330 |
Health Information Services | 26.99% |
|
Carelabs Co.Ltd
KQ:263700 |
Health Information Services | 7.01% |
|
Shanghai Kingstar Winning Software
SHE:300253 |
Health Information Services | 0.03% |
|
Longmaster Information Tech
SHE:300288 |
Health Information Services | 0.68% |
Annual Asset Resilience Ratio for Zhejiang Taimei Medical Technology Co., Ltd. (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Taimei Medical Technology Co., Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 55.59% | €880.09 Million | €1.58 Billion | +17.51pp |
| 2023-12-31 | 38.08% | €550.06 Million | €1.44 Billion | -2.53pp |
| 2022-12-31 | 40.60% | €741.08 Million | €1.83 Billion | +0.69pp |
| 2021-12-31 | 39.91% | €720.30 Million | €1.80 Billion | -- |